课题基金 / 基金详情

Genetically-engineered pig kidney transplantation in baboons: reducing the adaptive immune response and monitoring graft function

Genetically-engineered pig kidney transplantation in baboons: reducing the adaptive immune response and monitoring graft function
狒狒基因工程猪肾移植:降低适应性免疫反应并监测移植物功能
批准号:
10019098
负责人:
DAVID KC COOPER
金额:
$29.95万
依托单位国家:
美国
项目类别:
财政年份:
2010
资助国家:
美国
项目状态:
未结题
起止时间:
2010-08-01 至 2025-05-31

项目摘要

项目成果

DAVID KC COOPER的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
GENETICALLY-ENGINEERED PIG ORGAN TRANSPLANTATION IN BABOONS: IMMUNOLOGICAL AND FUNCTIONAL STUDIES PROJECT 1: Genetically-engineered pig kidney transplantation in baboons: reducing the adaptive immune response and monitoring graft function (Project Lead: David K.C Cooper) PROJECT SUMMARY/ABSTRACT Considerable advances have been made in the results of life-supporting genetically- engineered (GE) pig kidney transplantation (Tx) in nonhuman primates (NHPs), with graft and recipient survival in months or even years. Since the barrier of the innate immune response has largely been overcome, we will direct most of our attention to (i) reducing the adaptive immune response, and (ii) investigating the potential physiological incompatibilities between pigs and NHPs. We will first test kidney transplants from pigs with the most advanced genetic- engineering to date, i.e., pigs with 8 genetic manipulations (8GE pigs), all aimed towards protecting the kidney from the primate immune response. We will compare two immunosuppressive regimens, in one using a novel costimulation blockade agent that has not been tested in a xenotransplantation model previously. Using the preferred regimen, we will then transplant kidneys from 8GE pigs additionally transgenic for expression of programmed death ligand 1 (PG-L1), which should allow successful organ Tx with a reduced exogenous immunosuppressive therapy. We predict that kidneys from these pigs, using the preferred immunosuppressive regimen, will function for 6 months in the absence of immune-related injury, thus allowing a comprehensive study of renal function to determine whether there are physiological incompatibilities that might require attention. Offering patients with end-stage renal disease a timely pig kidney transplant without excessive exogenous immunosuppressive therapy would allow many more patients to receive kidney transplants, and reduce the need for chronic dialysis. 1
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Alemtuzumab and Regulatory T Cells for Heart Transplant Tolerance in Monkeys
Genetically-engineered pig organ transplantation into nonhuman primates
Genetically-engineered pig organ transplantation into nonhuman primates
Administrative Core
海外基金